Sunday, June 28, 2026

Why Prosecutor Park Sang-yong Refused to Testify: The Controversial Double-Flow North Korean Remittance Case Explained

Prosecutor Park Sang-yong refuses to take an oath during a hearing on the Ssangbangwool North Korea Fund Transfer case, sparking political conflict.

Apple Set to Launch First Foldable iPhone in September Alongside iPhone 18

Apple plans to launch its first foldable iPhone this fall, featuring a book-style design and addressing common foldable issues.

China’s Dangerous Gambit: Why Stronger N.K. Ties Should Terrify Washington

North Korean Foreign Minister Choe Son-hui met with Chinese counterpart Wang Yi in Beijing, discussing bilateral relations and regional stability.

Tag: Hanmi Pharmaceutical

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

Hanmi Pharmaceutical’s Leadership Shake-Up: What Does New CEO Hwang Sang-yeon Mean for the Future?

Hanmi Pharmaceutical Group's management dispute appears to be resolved, marking its first external leadership in 53 years.

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

How MiniRin and Nokdernah Are Revolutionizing Nocturia Care for Seniors: A Comprehensive Guide

Hanmi Pharmaceutical and Ferring Korea partner to distribute Minirin and Nocdurna for nocturia treatment, enhancing patient access.

Top News

- Our Sponsors Ad -

Follow us